[Effect of methergoline on impulse secretion of gonadotropins in women with hyperprolactinemic ovarian insufficiency].
The impact of methergoline, a serotonin antagonist, on the levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), prolactin, estradiol and progesterone was studied in the blood serum of 20 females with hyperprolactinemia-induced ovarian insufficiency who were under a ten-day course of its administration in a dose of 4-12 mg/day. Two patients were studied for gonadotrophin impulse secretion before and during methergoline treatment. It was revealed that the administration of the preparation led to a significant elevation of serum FSH and LH, estradiol and progesterone levels (up to the values characteristic of the preovulation phase) and enhancement of LH impulse secretion by the pituitary body. The possibility of dominant follicle growth and development was stated in the presence of persistent hyperprolactinemia. The authors supposed that the agent's effect was gained due to an enhanced secretion of the gonadotrophin-releasing hormone by the hypothalamus.
Potin
V V
VV
Svechnikova
F A
FA
Soboleva
E L
EL
D000293:Adolescent; D000328:Adult; D000858:Anovulation / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008711:Metergoline / Q000627:therapeutic use*; D013268:Stimulation, Chemical
D004873:Ergolines; D006065:Gonadotropins, Pituitary; D008711:Metergoline
Vliianie metergolina na impu'lsnuiu sekretsiiu gonadotropinov u zhenshchin s giperprolaktinemicheskoĭ nedostatochnos'tiu iaichnikov.